Polaris Venture Partners Founders' Fund V, L.P. insider trades: Lyra Therapeutics (LYRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Polaris Venture Partners Founders' Fund V, L.P. reports to the SEC
and 8 more companies
Open-market buys and sales
43 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 5, 2020 | LYRA | ↑ Buy | 62,500 | $16.00 | $1.0M | Indirect | May 6, 2020 (1d) |
| May 5, 2020 | LYRA | ↓ Sell | 9,674 | $16.00 | $155K | Indirect | May 6, 2020 (1d) |
| Dec 17, 2019 | PHR | ↓ Sell | 344,599 | $24.48 | $8.4M | By Polaris Venture Partners V, L.P. | Dec 18, 2019 (1d) |
| Dec 17, 2019 | PHR | ↓ Sell | 6,716 | $24.48 | $164K | By Polaris Venture Partners Entrepreneur | Dec 18, 2019 (1d) |
| Dec 17, 2019 | PHR | ↓ Sell | 3,446 | $24.48 | $84K | By Polaris Venture Partners Special Foun | Dec 18, 2019 (1d) |
| Dec 17, 2019 | PHR | ↓ Sell | 2,360 | $24.48 | $58K | By Polaris Venture Partners Founders' Fu | Dec 18, 2019 (1d) |
| Jul 22, 2019 | PHR | ↓ Sell | 382,887 | $18.00 | $6.9M | By Polaris Venture Partners V, L.P. | Jul 24, 2019 (2d) |
| Jul 22, 2019 | PHR | ↓ Sell | 7,462 | $18.00 | $134K | By Polaris Venture Partners Entrepreneur | Jul 24, 2019 (2d) |
| Jul 22, 2019 | PHR | ↓ Sell | 3,828 | $18.00 | $69K | By Polaris Venture Partners Special Foun | Jul 24, 2019 (2d) |
| Jul 22, 2019 | PHR | ↓ Sell | 2,622 | $18.00 | $47K | By Polaris Venture Partners Founders' Fu | Jul 24, 2019 (2d) |
| Jul 17, 2019 | CDLX | ↓ Sell | 68,727 | $27.66 | $1.9M | Indirect | Jul 17, 2019 (0d) |
| Jun 7, 2019 | CDLX | ↓ Sell | 100,000 | $25.62 | $2.6M | Indirect | Jun 11, 2019 (4d) |
| Jun 6, 2019 | CDLX | ↓ Sell | 75,284 | $24.10 | $1.8M | Indirect | Jun 6, 2019 (0d) |
| May 28, 2019 | CDLX | ↓ Sell | 100,000 | $23.04 | $2.3M | Indirect | May 30, 2019 (2d) |
| Sep 13, 2018 | CDLX | ↓ Sell | 150,000 | $25.04 | $3.8M | Indirect | Sep 14, 2018 (1d) |
| Nov 20, 2017 | ASNS | ↑ Buy | 500,000 | $10.00 | $5.0M | Indirect | Nov 20, 2017 (0d) |
| Jun 27, 2016 | SELB | ↑ Buy | 150,000 | $14.00 | $2.1M | Indirect | Jun 29, 2016 (2d) |
| Aug 5, 2015 | TTOO | ↓ Sell | 10,744 | $15.02 | $161K | Indirect | Aug 7, 2015 (2d) |
| Jul 24, 2015 | TTOO | ↓ Sell | 15,399 | $15.04 | $232K | Indirect | Jul 24, 2015 (0d) |
| Jul 22, 2015 | TTOO | ↓ Sell | 44,997 | $15.57 | $700K | Indirect | Jul 22, 2015 (0d) |
| Jul 17, 2015 | TTOO | ↓ Sell | 44,997 | $16.26 | $732K | Indirect | Jul 17, 2015 (0d) |
| Jul 14, 2015 | TTOO | ↓ Sell | 29,998 | $16.57 | $497K | Indirect | Jul 14, 2015 (0d) |
| Jul 10, 2015 | TTOO | ↓ Sell | 44,997 | $16.25 | $731K | Indirect | Jul 10, 2015 (0d) |
| Jul 7, 2015 | TTOO | ↓ Sell | 44,997 | $15.91 | $716K | Indirect | Jul 7, 2015 (0d) |
| Jul 1, 2015 | TTOO | ↓ Sell | 44,997 | $16.09 | $724K | Indirect | Jul 1, 2015 (0d) |
| Jun 26, 2015 | TTOO | ↓ Sell | 44,997 | $17.08 | $768K | Indirect | Jun 26, 2015 (0d) |
| Jun 23, 2015 | TTOO | ↓ Sell | 29,998 | $18.18 | $545K | Indirect | Jun 24, 2015 (1d) |
| Jun 19, 2015 | GNCA | ↓ Sell | 30,004 | $13.04 | $391K | By the Polaris Funds | Jun 19, 2015 (0d) |
| Jun 17, 2015 | GNCA | ↓ Sell | 56,618 | $13.20 | $747K | By the Polaris Funds | Jun 17, 2015 (0d) |
| Jun 15, 2015 | PULM | ↑ Buy | 106,693 | $6.88 | $734K | Indirect | Jun 17, 2015 (2d) |
| Feb 2, 2015 | OCUL | ↓ Sell | 500,000 | $29.50 | $14.8M | Indirect | Feb 4, 2015 (2d) |
| Aug 14, 2014 | TRVN | ↓ Sell | 36,702 | $6.04 | $222K | Indirect | Aug 18, 2014 (4d) |
| Aug 14, 2014 | GNCA | ↓ Sell | 9,660 | $13.01 | $126K | By the Polaris Funds | Aug 15, 2014 (1d) |
| Aug 13, 2014 | TRVN | ↓ Sell | 5,700 | $6.12 | $35K | Indirect | Aug 15, 2014 (2d) |
| Aug 12, 2014 | GNCA | ↓ Sell | 63,794 | $13.28 | $847K | By the Polaris Funds | Aug 12, 2014 (0d) |
| Apr 15, 2014 | CERU | ↑ Buy | 1,470,582 | $7.00 | $10.3M | Indirect | Apr 15, 2014 (0d) |
| Feb 10, 2014 | GNCA | ↑ Buy | 232,820 | $12.00 | $2.8M | Indirect | Feb 11, 2014 (1d) |
| Feb 5, 2014 | TRVN | ↑ Buy | 472,405 | $7.00 | $3.3M | Indirect | Feb 7, 2014 (2d) |
| Oct 4, 2013 | FATE | ↑ Buy | 804,112 | $6.00 | $4.8M | By Polaris Venture Partners V, L.P. | Oct 7, 2013 (3d) |
| Oct 4, 2013 | FATE | ↑ Buy | 15,672 | $6.00 | $94K | By Polaris Venture Partners Entrepreneur | Oct 7, 2013 (3d) |
| Oct 4, 2013 | FATE | ↑ Buy | 8,041 | $6.00 | $48K | By Polaris Venture Partners Special Foun | Oct 7, 2013 (3d) |
| Oct 4, 2013 | FATE | ↑ Buy | 5,508 | $6.00 | $33K | By Polaris Venture Partners Founders' Fu | Oct 7, 2013 (3d) |
| Sep 25, 2013 | BIND | ↑ Buy | 26,000 | $15.00 | $390K | Indirect | Sep 27, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LYRA insiders
Open-market trades in the last 12 months
About Polaris Venture Partners Founders' Fund V, L.P.'s insider trades
Polaris Venture Partners Founders' Fund V, L.P. is a 10% owner of Lyra Therapeutics (LYRA). Since Sep 25, 2013, it has reported 12 open-market purchases worth $30.6M and 31 sales worth $51.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (13 filings), option exercises (4 filings), other transactions (4 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LYRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.